Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Fitxers

627357.pdf (703.7 KB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2012-06-01

Tots els drets reservats

Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/109264

Fat Redistribution Syndromes Associated with HIV-1 Infection and Combination Antiretroviral Therapy

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

Resum

More than 15 years after the introduction of highly active antiretroviral therapy, HIV/HAART-associated lipodystrophy syndrome still shadows the indisputable efficacy of antiretroviral therapy. Several issues related to this complication (prevalence, diagnosis, pathogenesis, prevention, or clinical management) have not been completely clarified. However, in the last years, substantial progress has been made in elucidating some of these basic aspects. This includes a better knowledge of the pathogenic mechanisms underlying HIV/HAART-associated lipodystrophy syndrome such as genetic host determinants, the impact of HIV infection per se, as well as the contribution of antiretroviral therapy. In regard to treatment, we have learned that certain drugs are especially prone to cause HIV/HAART-associated lipodystrophy syndrome (i.e. thymidine analogues). Pharmacological interventions to treat this condition have yielded mostly disappointing results, and the only intervention which offers an immediate aesthetical improvement for patients with HIV/HAART-associated lipodystrophy syndrome is plastic surgery. Even under the most favorable conditions (ideal host genetic make-up, and the timely initiation of HIV therapy with less toxic drugs), current data show that HIV/HAART-associated lipodystrophy syndrome is a complication of HIV infection and/or antiretroviral treatment that we are unable to avoid. In the context of HIV-1-infected patients under long-term antiretroviral therapy, fat toxicity is still the dark side of the rainbow.

Matèries

Infeccions per VIH, Medicaments antivírics, Síndrome de lipodistròfia associada a VIH, Cirurgia plàstica

Matèries (anglès)

HIV infections, Antiviral agents, HIV-associated lipodystrophy syndrome, Plastic surgery

Citació

Col·leccions

Articles publicats en revistes (Medicina)
Articles publicats en revistes (Bioquímica i Biomedicina Molecular)

Citació

DOMINGO, Pere (Domingo Pedrol), et al. Fat Redistribution Syndromes Associated with HIV-1 Infection and Combination Antiretroviral Therapy. AIDS Reviews. 2012. Vol. 14, num. 2, pags. 112-123. ISSN 1139-6121. [consulted: 11 of August of 2026]. Available at: https://hdl.handle.net/2445/109264

Exportar metadades

JSON - METS

Compartir registre